Telix has dosed the first patient in a Phase 3 [...]
Telix Pharmaceuticals has received FDA agreement on the protocol and [...]
Phase 3 data presented at ASCO 2026 suggest a PSMA-targeted [...]
Regeneron Pharmaceuticals has entered the radiopharmaceuticals field through a multi-programme [...]
Telix Pharmaceuticals has reached agreement with the US Food and [...]
Bringing you the latest industry news and insights every day
Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596
© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design
